Literature DB >> 24456626

Statistical methods for the assessment of EQAPOL proficiency testing: ELISpot, Luminex, and Flow Cytometry.

Wes Rountree1, Nathan Vandergrift2, John Bainbridge2, Ana M Sanchez2, Thomas N Denny2.   

Abstract

In September 2011 Duke University was awarded a contract to develop the National Institutes of Health/National Institute of Allergy and Infectious Diseases (NIH/NIAID) External Quality Assurance Program Oversight Laboratory (EQAPOL). Through EQAPOL, proficiency testing programs are administered for Interferon-γ (IFN-γ) Enzyme-linked immunosorbent spot (ELISpot), Intracellular Cytokine Staining Flow Cytometry (ICS) and Luminex-based cytokine assays. One of the charges of the EQAPOL program was to apply statistical methods to determine overall site performance. We utilized various statistical methods for each program to find the most appropriate for assessing laboratory performance using the consensus average as the target value. Accuracy ranges were calculated based on Wald-type confidence intervals, exact Poisson confidence intervals, or via simulations. Given the nature of proficiency testing data, which has repeated measures within donor/sample made across several laboratories; the use of mixed effects models with alpha adjustments for multiple comparisons was also explored. Mixed effects models were found to be the most useful method to assess laboratory performance with respect to accuracy to the consensus. Model based approaches to the proficiency testing data in EQAPOL will continue to be utilized. Mixed effects models also provided a means of performing more complex analyses that would address secondary research questions regarding within and between laboratory variability as well as longitudinal analyses.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  ELISpot; Flow Cytometry; Luminex; Mixed effects models; Poisson; Proficiency testing

Mesh:

Substances:

Year:  2014        PMID: 24456626      PMCID: PMC4104253          DOI: 10.1016/j.jim.2014.01.007

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  22 in total

1.  Normal values for blood constituents; inter-hospital differences.

Authors:  I D P WOOTTON; E J KING
Journal:  Lancet       Date:  1953-03-07       Impact factor: 79.321

2.  Quality assurance of intracellular cytokine staining assays: analysis of multiple rounds of proficiency testing.

Authors:  Maria C Jaimes; Holden T Maecker; Ming Yan; Vernon C Maino; Mary Beth Hanley; Angela Greer; Janice M Darden; M Patricia D'Souza
Journal:  J Immunol Methods       Date:  2010-08-19       Impact factor: 2.303

3.  The five-parameter logistic: a characterization and comparison with the four-parameter logistic.

Authors:  Paul G Gottschalk; John R Dunn
Journal:  Anal Biochem       Date:  2005-08-01       Impact factor: 3.365

4.  A survey of the accuracy of chemical analyses in clinical laboratories.

Authors:  W P BELK; F W SUNDERMAN
Journal:  Am J Clin Pathol       Date:  1947-11       Impact factor: 2.493

5.  Results of the flow cytometry ACTG quality control program: analysis and findings.

Authors:  H Paxton; P Kidd; A Landay; J Giorgi; N Flomenberg; E Walker; F Valentine; J Fahey; R Gelman
Journal:  Clin Immunol Immunopathol       Date:  1989-07

6.  Evaluation of multiplexed cytokine and inflammation marker measurements: a methodologic study.

Authors:  Anil K Chaturvedi; Troy J Kemp; Ruth M Pfeiffer; Angelique Biancotto; Marcus Williams; Stella Munuo; Mark P Purdue; Ann W Hsing; Ligia Pinto; J Philip McCoy; Allan Hildesheim
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-06-29       Impact factor: 4.254

7.  Intra-individual variation of plasma adipokine levels and utility of single measurement of these biomarkers in population-based studies.

Authors:  Sang-Ah Lee; Asha Kallianpur; Yong-Bing Xiang; Wanqing Wen; Qiuyin Cai; Dake Liu; Sergio Fazio; MacRae F Linton; Wei Zheng; Xiao Ou Shu
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2007-11       Impact factor: 4.254

8.  Reproducibility and correlations of multiplex cytokine levels in asymptomatic persons.

Authors:  Hui-Lee Wong; Ruth M Pfeiffer; Thomas R Fears; Roel Vermeulen; Shaoquan Ji; Charles S Rabkin
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-12       Impact factor: 4.254

9.  Validity of multiplex-based assays for cytokine measurements in serum and plasma from "non-diseased" subjects: comparison with ELISA.

Authors:  Laure Dossus; Susen Becker; David Achaintre; Rudolf Kaaks; Sabina Rinaldi
Journal:  J Immunol Methods       Date:  2009-09-10       Impact factor: 2.303

10.  Equivalence of ELISpot assays demonstrated between major HIV network laboratories.

Authors:  Dilbinder K Gill; Yunda Huang; Gail L Levine; Anna Sambor; Donald K Carter; Alicia Sato; Jakub Kopycinski; Peter Hayes; Bridget Hahn; Josephine Birungi; Tony Tarragona-Fiol; Hong Wan; Mark Randles; Andrew Raxworthy Cooper; Aloysius Ssemaganda; Lorna Clark; Pontiano Kaleebu; Steven G Self; Richard Koup; Blake Wood; M Juliana McElrath; Josephine H Cox; John Hural; Jill Gilmour
Journal:  PLoS One       Date:  2010-12-14       Impact factor: 3.240

View more
  9 in total

1.  The External Quality Assurance Oversight Laboratory (EQAPOL) proficiency program for IFN-gamma enzyme-linked immunospot (IFN-γ ELISpot) assay.

Authors:  Ana M Sanchez; Wes Rountree; Mark Berrong; Ambrosia Garcia; Alexandra Schuetz; Josephine Cox; Nicole Frahm; Mark Manak; Marcella Sarzotti-Kelsoe; M Patricia D'Souza; Thomas Denny; Guido Ferrari
Journal:  J Immunol Methods       Date:  2014-03-28       Impact factor: 2.303

Review 2.  Development and implementation of a proficiency testing program for Luminex bead-based cytokine assays.

Authors:  Heather E Lynch; Ana M Sanchez; M Patricia D'Souza; Wes Rountree; Thomas N Denny; Michael Kalos; Gregory D Sempowski
Journal:  J Immunol Methods       Date:  2014-05-04       Impact factor: 2.303

3.  Toward development of a comprehensive external quality assurance program for polyfunctional intracellular cytokine staining assays.

Authors:  Janet S Staats; Jennifer H Enzor; Ana M Sanchez; Wes Rountree; Cliburn Chan; Maria Jaimes; Ray Chun-Fai Chan; Amitabh Gaur; Thomas N Denny; Kent J Weinhold
Journal:  J Immunol Methods       Date:  2014-06-23       Impact factor: 2.303

4.  Variability of the IFN-γ ELISpot assay in the context of proficiency testing and bridging studies.

Authors:  Wes Rountree; Mark Berrong; Ana M Sanchez; Thomas N Denny; Guido Ferrari
Journal:  J Immunol Methods       Date:  2016-03-25       Impact factor: 2.303

5.  Introduction to a Special Issue of the Journal of Immunological Methods: Building global resource programs to support HIV/AIDS clinical trial studies.

Authors:  Ana M Sanchez; Thomas N Denny; Maurice O'Gorman
Journal:  J Immunol Methods       Date:  2014-06-06       Impact factor: 2.303

6.  The Statistical Value of Raw Fluorescence Signal in Luminex xMAP Based Multiplex Immunoassays.

Authors:  Edmond J Breen; Woei Tan; Alamgir Khan
Journal:  Sci Rep       Date:  2016-05-31       Impact factor: 4.379

7.  Performance of International AIDS Vaccine Initiative African clinical research laboratories in standardised ELISpot and peripheral blood mononuclear cell processing in support of HIV vaccine clinical trials.

Authors:  Robert K Langat; Bashir Farah; Jackton Indangasi; Simon Ogola; Gloria Omosa-Manyonyi; Omu Anzala; Jean Bizimana; Emmanuel Tekirya; Caroline Ngetsa; Moses Silwamba; Enoch Muyanja; Paramesh Chetty; Maureen Jangano; Nancy Hills; Jill Gilmour; Len Dally; Josephine H Cox; Peter Hayes
Journal:  Afr J Lab Med       Date:  2021-02-17

Review 8.  How Can Elispot Add Information to Improve Knowledge on Tropical Diseases?

Authors:  Josué da Costa Lima-Junior; Fernanda Nazaré Morgado; Fátima Conceição-Silva
Journal:  Cells       Date:  2017-09-29       Impact factor: 6.600

9.  Development of an international external quality assurance program for HIV-1 incidence using the Limiting Antigen Avidity assay.

Authors:  Sheila M Keating; Wes Rountree; Eduard Grebe; Andrea L Pappas; Mars Stone; Dylan Hampton; Christopher A Todd; Marek S Poniewierski; Ana Sanchez; Cassandra G Porth; Thomas N Denny; Michael P Busch
Journal:  PLoS One       Date:  2019-09-16       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.